|
At each Conference, patients and family members are given the wonderful opportunity to have dinner with some of the top physicians and nurses in the field. Don’t miss out on this unique opportunity!
Learn more about who's scheduled to host a table and what topics they plan to talk about
View transcript from May 14 chat
PHA staff will be in Toronto, Canada, this coming weekend for the American Thoracic Society Conference to network, educate and raise awareness among medical professionals. This year there are over 45 sessions on PH and PHA will be presenting a poster on PHA at the Patient Advisory Roundtable. If you're attending ATS, come by the PHA booth and check out the resources we have for you. We also encourage you to participate in the fundraiser Gilead will be hosting for PHA where participants will be challenged to answer questions about pulmonary hypertension, and for each correct answer, Gilead will make a donation to PHA. If you are planning to attend ATS, register in advance at www.masteringpah.com to double the donation for each correct answer!
5/10/08 HIV, but Not HHV-8, Found to Increase Risk of Pulmonary Arterial Hypertension
5/9/08 MPs in Canada Back Orphan Drug Proposal
5/7/08 UC San Diego Physician Receives Ellis Island Medal of Honor
5/6/08 Treprostinil Data to be Webcast from Annual Meeting of the American Thoracic Society
5/1/08 Gilead Initiates Letairis® (ambrisentan) Phase IV Program
4/29/08 “The Global Learning Series” to Raise Awareness of PAH in an Episode Called “Understanding The Heart”
4/28/08 Teva Announces Approval of Generic Flolan® for Injection
4/25/08 GlaxoSmithKline's Volibris (ambrisentan) Receives Authorization From the European Commission
|